» Articles » PMID: 28624236

Regulation of the Proprotein Convertases Expression and Activity During Regenerative Angiogenesis: Role of Hypoxia-inducible Factor (HIF)

Overview
Journal Eur J Cell Biol
Publisher Elsevier
Specialty Cell Biology
Date 2017 Jun 19
PMID 28624236
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Proprotein convertases (PCs) are involved in various physiological and pathological processes ranging from embryogenesis to carcinogenesis. Here, using the zebrafish fin regeneration model, we report induced expression of furin and PC5 but not PACE4 and PC7 during fin regeneration that is associated with increased PC activity. Stabilization of HIF by cobalt chloride (CoCl further increases these processes. The use of the general PC-inhibitor decanoyl-RVKR-cholromethyl ketone (CMK) inhibited control and CoCl-induced PC activity. CoCl inhibits embryonic zebrafish ZF4 cell proliferation and caudal fin regeneration that is associated with the expression of the anti-proliferative genes P21, P16, PC3 and P53 in ZF4 cells and in non-regenerating stump tissues. In contrast, during fin regeneration, HIF stabilization failed to promote the expression of these anti-proliferative genes and maintained high expression of cyclin D. Further analysis revealed that CoCl maintained the formation of immature regenerating vasculature that was associated with amplified expression of OCT4 and various angiogenic factors reported to be PC substrates and/or downstream effectors. These findings revealed that while furin and PC5 expression/activity and their substrates/effectors are regulated during fin regeneration, HIF stabilization by CoCl has the potential to modulate these processes and impact on the regenerative process and vessels organization.

Citing Articles

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression.

Pernot S, Tome M, Galeano-Otero I, Evrard S, Badiola I, Delom F Front Immunol. 2024; 14:1278630.

PMID: 38250065 PMC: 10796450. DOI: 10.3389/fimmu.2023.1278630.


Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors.

Descarpentrie J, Arauzo-Bravo M, He Z, Francois A, Gonzalez A, Garcia-Gallastegi P Cancers (Basel). 2022; 14(5).

PMID: 35267511 PMC: 8909039. DOI: 10.3390/cancers14051195.


The proprotein convertase furin in cancer: more than an oncogene.

He Z, Khatib A, Creemers J Oncogene. 2022; 41(9):1252-1262.

PMID: 34997216 DOI: 10.1038/s41388-021-02175-9.


HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review.

Hirota K Biomedicines. 2021; 9(5).

PMID: 33923349 PMC: 8146675. DOI: 10.3390/biomedicines9050468.


Furin Prodomain ppFurin Enhances Ca Entry Through Orai and TRPC6 Channels' Activation in Breast Cancer Cells.

Lopez J, Siegfried G, Cantonero C, Soulet F, Descarpentrie J, Smani T Cancers (Basel). 2021; 13(7).

PMID: 33916304 PMC: 8037623. DOI: 10.3390/cancers13071670.